Medasense Biometrics LTD

28/04/2026

We’re closely supporting clinicians as they integrate NOL monitoring into their anesthesia workflows, including in Mexico, where Dr. Javier Alvarado Perez is taking a clear step toward personalized pain management in the OR.

Working with several hospitals, he recently integrated NOL monitoring into his clinical practice, driven by a strong belief in the importance of measuring and actively managing intraoperative nociception.

He’s using NOL during TIVA cases, allowing him to continuously assess the patient’s nociceptive response and tailor opioid dosing aimed at smoother recovery.

As more clinicians move beyond indirect signs like heart rate and blood pressure toward physiology-based insight, these real-world integrations show how nociception monitoring fits naturally into routine care while supporting better-informed clinical decisions.

Great to see this momentum building across LATAM!

More to come.

14/04/2026

Discover NOL nociception monitoring innovation in Phoenix this week, at - 51st Annual Regional Anesthesiology and Acute Pain Medicine Meeting, April 16-18, 2026.

Meet us at the Medasense booth to learn how AI-powered NOL monitoring enables anesthesiologists to:

· Provide personalized, physiology-guided analgesic titration
· Quantify the effectiveness of regional blocks in real time
· Integrate NOL into multimodal strategies for improved recovery
· Enhance patient safety and recovery

Schedule a meeting 👉🏼 Holly Stewart

The American Society of Regional Anesthesia and Pain Medicine

31/03/2026

Medasense is proud to announce a clinical collaboration with Jefferson Health, a leading U.S. academic medical center, through the Israel-U.S. HealthTech Pilot Program, a joint initiative of the Israel Innovation Authority and Thomas Jefferson University.

The two parties will conduct a clinical study to examine the clinical and economic benefits of implementing Medasense’s Nociception Level Index (NOL) technology during spine surgery procedures.

Spine surgery is a high-volume area where optimizing analgesia and pain management remains a real challenge. So with ~3,000 spine procedures performed annually at Jefferson’s academic medical center, the study will generate real-world clinical and economic evidence on how objective nociception monitoring can support more personalized, data-driven care.

Another step forward as Medasense continues building its U.S. evidence base and pushing toward a new standard for how pain is monitored and managed in operating rooms and critical care settings.

📢 Read the full press release here https://medasense.com/medasense-and-jefferson-health-to-collaborate-on-study-of-pain-monitoring-technology-in-spine-surgery/



רשות החדשנות

26/03/2026

We brought NOL monitoring to the stage on the XIII Update Conference in Anesthesiology, Resuscitation and Pain Management hosted by Hospital Universitari Dexeus in Barcelona.

Medasense’s Fabio Perestrelo addressed clinicians from across Catalonia, highlighting how AI-powered nociception monitoring can help clinicians improve intraoperative patient management, enabling automated interpretation and personalized analgesia titration.

Reach out to learn more about the NOL-Nociception Level Index® and how AI can support more precise, responsive decision-making in the operating room.



--
Llevamos la monitorización NOL al congreso XIII Jornadas de Actualización en Anestesiología, Reanimación y Tratamiento del Dolor organizado por el Hospital Universitari Dexeus en Barcelona.

Fabio Perestrelo, de Medasense, se dirigió a clínicos de toda Cataluña, destacando cómo la monitorización de la nocicepción basada en inteligencia artificial puede ayudar a mejorar el manejo intraoperatorio del paciente, permitiendo una interpretación automatizada y una titulación personalizada de la analgesia.

No dude en contactarnos para saber más sobre el índice NOL (NOL-Nociception Level Index®) y cómo la inteligencia artificial puede apoyar una toma de decisiones más precisa y dinámica en el quirófano.

23/03/2026

¡Hoy!🎙️ La IA como aliada para controlar el estrés quirúrgico – webinar en directo en español 👉 Regístrate ahora para unirte en directo o recibir la grabación.

🎙️ 𝐋𝐚 𝐈𝐀 𝐜𝐨𝐦𝐨 𝐚𝐥𝐢𝐚𝐝𝐚 𝐩𝐚𝐫𝐚 𝐜𝐨𝐧𝐭𝐫𝐨𝐥𝐚𝐫 𝐞𝐥 𝐞𝐬𝐭𝐫𝐞́𝐬 𝐪𝐮𝐢𝐫𝐮́𝐫𝐠𝐢𝐜𝐨 – Un webinar en directo en español

Únete a un panel de clínicos experimentados el lunes 23 de marzo de 2026 para debatir cómo la monitorización de NOL impulsada por IA está contribuyendo a un enfoque más informado de la nocicepción intraoperatoria y el manejo de la anestesia:

- Ignacio Gonzalez Campos, DVM (Moderador), Director Médico, Experto en la Industria Médica, España
- Elena María Pérez Bergara, MD, Hospital Universitario Navarra, Pamplona, Navarra, España
- Ariel Grass, MD, Shaare Zedek Medical Center, Jerusalem, Israel

Obtendrás información sobre:

🌟 ¿Cómo ayuda la monitorización de la nocicepción NOL impulsada por IA a controlar el estrés quirúrgico y a personalizar el manejo del dolor?

🌟 Uso de datos objetivos para apoyar las decisiones analgésicas en tiempo real

🌟 Integración práctica del Indice de Nivel de Nocicepción NOL en la práctica rutinaria de anestesia

Registrate ahora! 👉 https://us02web.zoom.us/webinar/register/5117738221153/WN_I1ZPzgTNQc6jVZfJOb8Wuw

---

🎙️ 𝐇𝐚𝐫𝐧𝐞𝐬𝐬𝐢𝐧𝐠 𝐀𝐈 𝐭𝐨 𝐌𝐚𝐧𝐚𝐠𝐞 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐒𝐭𝐫𝐞𝐬𝐬 – A Live Webinar in Spanish!

Join a panel of experienced clinicians on Monday, March 23, 2026 to discuss how AI-powered NOL monitoring is contributing to a more informed approach to intraoperative nociception and anesthesia management:

- Ignacio Gonzalez Campos, DVM (Moderator), Medical Director, Medical Industry Expert, Spain
- Elena María Pérez Bergara, MD, Hospital Universitario Navarra, Pamplona, Navarre, Spain
- Ariel Grass, MD, Shaare Zedek Medical Center, Jerusalem, Israel

You’ll gain insights on:

🌟 How AI-powered NOL nociception monitoring helps control surgical stress and personalize pain management

🌟 Using objective data to inform analgesic decisions in real time

🌟 Practical integration of the NOL-Nociception Level Index® into routine anesthesia practice

Register now! 👉 https://us02web.zoom.us/webinar/register/5117738221153/WN_I1ZPzgTNQc6jVZfJOb8Wuw

19/03/2026

🌎 AI-powered NOL nociception monitoring - making its way across LATAM.
Last week at the TIVA Veracruz Course-Workshop our NOL session focused on the benefits of NOL-Nociception Level Index® monitoring for personalized analgesia with TIVA.
Always more engaging with our immersive VR experience bringing clinical learning to life!

We also joined forces with TIVA Mexico for a live OR session with NOL, streamed in real time to the participants in Veracruz. That collaboration led to some great insights and lively discussion between the clinicians.

Many thanks to de Anestesiologos del Estado de Veracruz, A.C., for hosting the sessions, to Dr. Arnulfo Calixto Flores for sharing his experience using NOL, and to our LATAM Manager Roberto Antonio Soto doing the legwork to reach and support anesthesiologists across the region with NOL.
👉🏽 Let us know if you’d like to learn more about NOL monitoring for your anesthesia practice.


--

🌎 Monitorización de la nocicepción NOL con IA: llegando a Latinoamérica.
La semana pasada, en el Curso-Taller de TIVA Veracruz, nuestra sesión sobre NOL se centró en los beneficios de la monitorización del Índice de Nivel de Nocicepción (NOL) para la analgesia personalizada con TIVA.
¡Una experiencia de realidad virtual inmersiva que da vida al aprendizaje clínico!

También colaboramos con TIVA México para una sesión práctica en el quirófano con NOL, transmitida en tiempo real a los participantes en Veracruz. Esta colaboración generó valiosas perspectivas y un animado debate entre los profesionales clínicos.

Muchas gracias al de Anestesiologos del estado de Veracruz, A.C., por organizar las sesiones, al Dr. Arnulfo Calixto Flores por compartir su experiencia usando NOL y a nuestro Gerente para Latinoamérica, Roberto Antonio Soto, por su labor en el terreno para llegar a los anestesiólogos de toda la región y brindarles apoyo con NOL.

👉🏽 Si desea obtener más información sobre la monitorización del NOL para su práctica de anestesia, contáctenos.

18/03/2026

🎙️ 𝐋𝐚 𝐈𝐀 𝐜𝐨𝐦𝐨 𝐚𝐥𝐢𝐚𝐝𝐚 𝐩𝐚𝐫𝐚 𝐜𝐨𝐧𝐭𝐫𝐨𝐥𝐚𝐫 𝐞𝐥 𝐞𝐬𝐭𝐫𝐞́𝐬 𝐪𝐮𝐢𝐫𝐮́𝐫𝐠𝐢𝐜𝐨 – Un webinar en directo en español

Únete a un panel de clínicos experimentados el lunes 23 de marzo de 2026 para debatir cómo la monitorización de NOL impulsada por IA está contribuyendo a un enfoque más informado de la nocicepción intraoperatoria y el manejo de la anestesia:

- Ignacio Gonzalez Campos, DVM (Moderador), Director Médico, Experto en la Industria Médica, España
- Elena María Pérez Bergara, MD, Hospital Universitario Navarra, Pamplona, Navarra, España
- Ariel Grass, MD, Shaare Zedek Medical Center, Jerusalem, Israel

Obtendrás información sobre:

🌟 ¿Cómo ayuda la monitorización de la nocicepción NOL impulsada por IA a controlar el estrés quirúrgico y a personalizar el manejo del dolor?

🌟 Uso de datos objetivos para apoyar las decisiones analgésicas en tiempo real

🌟 Integración práctica del Indice de Nivel de Nocicepción NOL en la práctica rutinaria de anestesia

Registrate ahora! 👉 https://us02web.zoom.us/webinar/register/5117738221153/WN_I1ZPzgTNQc6jVZfJOb8Wuw

---

🎙️ 𝐇𝐚𝐫𝐧𝐞𝐬𝐬𝐢𝐧𝐠 𝐀𝐈 𝐭𝐨 𝐌𝐚𝐧𝐚𝐠𝐞 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐒𝐭𝐫𝐞𝐬𝐬 – A Live Webinar in Spanish!

Join a panel of experienced clinicians on Monday, March 23, 2026 to discuss how AI-powered NOL monitoring is contributing to a more informed approach to intraoperative nociception and anesthesia management:

- Ignacio Gonzalez Campos, DVM (Moderator), Medical Director, Medical Industry Expert, Spain
- Elena María Pérez Bergara, MD, Hospital Universitario Navarra, Pamplona, Navarre, Spain
- Ariel Grass, MD, Shaare Zedek Medical Center, Jerusalem, Israel

You’ll gain insights on:

🌟 How AI-powered NOL nociception monitoring helps control surgical stress and personalize pain management

🌟 Using objective data to inform analgesic decisions in real time

🌟 Practical integration of the NOL-Nociception Level Index® into routine anesthesia practice

Register now! 👉 https://us02web.zoom.us/webinar/register/5117738221153/WN_I1ZPzgTNQc6jVZfJOb8Wuw

25/02/2026

We’re excited to announce that Peter Wehrly has joined Medasense as Executive Chairman of the Board.

Over the past 15 years, Peter has led innovative medical technology companies through regulatory approval, U.S. commercialization, strategic partnerships, and successful exits. He has a strong track record of bringing novel technologies from development into scalable revenue growth.

His experience in building commercial infrastructure and strategic alliances is closely aligned with Medasense’s next phase of expansion.

We look forward to working together to accelerate global adoption of NOL monitoring.

Read the full Press Release here 👉 https://www.einpresswire.com/article/893696188/medasense-appoints-medtech-leader-peter-wehrly-as-executive-chairman-of-the-board

24/02/2026

Its great to be at the CRASH Annual Conference in Colorado this week!

Jessica and Holly are representing Medasense at our booth, connecting with anesthesiologists and nurse anesthetists who are passionate about advancing patient care.

One of the standout presentations focused on opioid variation in anesthesia practice and the variability in intraoperative pain treatment across providers and institutions. Even within similar procedures, opioid dosing strategies can differ widely, raising important questions about consistency, personalization, and outcomes.

If you’re at CRASH, come and say hello!

17/02/2026

[𝘚𝘱𝘢𝘯𝘪𝘴𝘩 𝘵𝘳𝘢𝘯𝘴𝘭𝘢𝘵𝘪𝘰𝘯 𝘣𝘦𝘭𝘰𝘸] 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐢𝐧𝐠 𝐀𝐧𝐚𝐥𝐠𝐞𝐬𝐢𝐚 𝐭𝐨 𝐈𝐦𝐩𝐫𝐨𝐯𝐞 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐎𝐮𝐭𝐜𝐨𝐦𝐞𝐬: 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐃𝐫. Nora Veiga Gil

We are thrilled to see the clinical impact of NOL monitoring highlighted in the latest article by Dr. Leonor Veiga Gil (University Hospital of Navarra).

In her paper ‘Intraoperative Nociception Monitoring’, she highlights why monitoring nociception is essential for modern anesthesia and how routine implementation of NOL monitoring leads to better patient outcomes in her practice:

🔸 Reduced Pain Intensity: Studies show that guiding opioid administration with NOL significantly reduces postoperative pain intensity (Meijer at al, van der Wal et al).
🔸 Fewer Complications: Controlling the intraoperative stress response with autonomic based nociception monitoring helps prevent postoperative complications.
🔸 Preventing Chronic Pain: Optimal intraoperative care may prevent peripheral or central nervous system sensitization, reducing the risk of persistent or chronic pain.

𝑻𝒉𝒆 𝑴𝒊𝒔𝒔𝒊𝒏𝒈 𝑳𝒊𝒏𝒌 𝒊𝒏 𝑷𝒆𝒓𝒔𝒐𝒏𝒂𝒍𝒊𝒛𝒂𝒕𝒊𝒐𝒏:
Just as we rely on EEG for depth-of-anesthesia and hemodynamic monitors for stability, NOL provides the critical data needed to personalize analgesia. By moving beyond heart rate and blood pressure, which are not sufficiently sensitive, clinicians can ensure every patient receives the exact dose they need.

👉 Read the full article by Dr. Veiga Gil here: https://lnkd.in/e7bywCC3

Nos complace enormemente ver el impacto clínico de la monitorización NOL destacado en el último artículo de la Dra. Leonor Veiga Gil

En su trabajo "Monitorización de la nocicepción intraoperatoria", la doctora destaca por qué monitorizar la nocicepción es esencial para la anestesia moderna y cómo la implementación rutinaria de la monitorización NOL conduce a mejores resultados para los pacientes en su práctica clínica:

🔸 Reducción de la intensidad del dolor: Los estudios demuestran que guiar la administración de opioides con NOL reduce significativamente la intensidad del dolor postoperatorio
🔸 Menos complicaciones: El control de la respuesta al estrés intraoperatorio mediante la monitorización de la nocicepción basada en el sistema autonómico ayuda a prevenir complicaciones postoperatorias
🔸 Prevención del dolor crónico: Una atención intraoperatoria óptima puede prevenir la sensibilización del sistema nervioso periférico o central, reduciendo el riesgo de dolor persistente o crónico

El enlace perdido en la personalización: Del mismo modo que confiamos en el EEG para la profundidad anestésica y en los monitores hemodinámicos para la estabilidad, el NOL proporciona los datos críticos necesarios para personalizar la analgesia. Al ir más allá de la frecuencia cardíaca y la presión arterial, que no son lo suficientemente sensibles, los médicos pueden asegurar que cada paciente reciba la dosis exacta que necesita.